RxDoctor Payments Data

Paul Naour, MD

Interventional Pain Medicine · Champaign, ILNPI 1144206178

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $415 and has fallen 55.7% since, to $184 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in IL, where the typical reported total is $2,254.

$1,294in general payments, 2019–2025

Across 34 payments — averaging $38.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$255
  • Medtronic$246
  • MML US, Inc.$196
  • AbbVie$124
  • Nalu Medical, Inc.$101
  • Pacira Pharmaceuticals Incorporated$93
  • plus $279 from 8 others

What the payments were for

  • Food & beverage$1,294100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,294 in reported general payments places this provider in the 45th percentile of 93 interventional pain medicine providers in Illinois.

See all interventional pain medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$295,851
Medicare patients
486
Services billed
26,985

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin230$8,118
Gabapentin400$5,771
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen232$3,687
Tramadol Hcl197$898
Morphine Sulfate ErMorphine Sulfate26$561
Duloxetine Hcl34$557
Baclofen40$505
Tizanidine Hcl24$391
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$240
Methylprednisolone48$192
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen30$190
Topiramate20$166
Meloxicam19$78
Cyclobenzaprine Hcl14$54
Alprazolam54$43

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Champaign

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →